Neuphoria Therapeutics Inc (NEUP) — Strategic Asset Allocation Index
Neuphoria Therapeutics Inc (NEUP) has a Strategic Asset Allocation Index of 0.3% as of December 2023. Strategic assets (PP&E of $- plus long-term investments of $81.07K) total $81.07K, measured against net assets of $29.04 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Neuphoria Therapeutics Inc Strategic Asset Allocation Index (2021–2021)
This chart shows how Neuphoria Therapeutics Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of December 2023, the index stands at 0.3%, representing strategic assets of $81.07K against net assets of $29.04 Million USD. Explore NEUP cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Neuphoria Therapeutics Inc (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Neuphoria Therapeutics Inc from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Neuphoria Therapeutics Inc worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.3% | $119.00K | $- | $119.00K | $35.76 Million | — |